TRA Life and Health

Logo_UBo_TRA_ohne Uni_web.png
© .

The TRA Life and Health provides a space for deepening our understanding of life across theoretical boundaries - studying everything from the tiniest molecules to the interaction of different organisms within ecosystems. Researchers from the fields of medicine, life sciences, pharmacy, nutrition research, mathematics and computer science are together studying - amongst others - organoids to better understand specific diseases or deploying artificial intelligence as a tool for neuroscience.

Research 

More about our research profile, topics and TRA projects.

About us

Find out more about our objectives,  members and TRA organization.

Offers

Find out more about research support and events organized by the TRA Life and Health.

 Technologies

Find an overview on infrastructure, facilities und technologies used in the TRA Life and Health's research area

News from the TRA

Notifications

University of Bonn Lands Two ERC Starting Grants
Bonn has again prevailed in competition for funding from the European Research Council (ERC), with researchers of the University of Excellence landing two prestigious ERC Starting Grants. Neuroscientist Professor Lukas Kunz, also associated with University Hospital Bonn (UKB), conducts research on how the human brain constructs the first-person perspective of our experiences. Dr. Riccardo Pennetta is leading a research project on large-scale quantum physics. The two researchers are to each receive approximately 1.5 million euros from the ERC for their projects over a five-years period.
A Ray of Hope in the Fight Against Cancer
Cancer is the second leading cause of death in Germany. In the search for new therapeutic approaches that target the uncontrolled growth of tumor cells, a class of enzymes known as cyclin-dependent kinases (CDKs) has come into focus. This is because this family of enzymes plays a fundamental role in gene expression and cell division. An overview of the current state of research on the transcriptional regulation of CDKs and the prospects for cancer treatment was compiled by Prof. Matthias Geyer of the University Hospital Bonn and the University of Bonn in collaboration with Prof. Robert P. Fisher of the Icahn School of Medicine at Mount Sinai, New York, and has now been published in Nature Reviews Drug Discovery. 
Malaria Causes Permanent Damage to Phagocytes in the Spleen
Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or “scavenger cells,” to a certain degree according to a study by the University of Bonn and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne. The researchers have demonstrated that malaria infection causes permanent damage to resident CD163 macrophages in the spleen, which are responsible for cleaning the blood, recycling iron and communicating with other cells involved in the body’s immune response. Their findings could harbor potential not only for more effective malaria vaccines but also for developing drugs and treatments to combat other infectious diseases. The paper is to be published in the journal “Immunity” but can already be accessed online.
Core2Edge: How tumor cells conquer the brain
Glioblastoma is an aggressive brain tumor that infiltrates deep into the surrounding brain tissue. Even after surgery, tumor cells remain in the brain and the tumor recurs. Researchers at the University Hospital Bonn (UKB) and the University of Bonn have now developed Core2Edge, a model based entirely on human tissue that captures these hard-to-access infiltration zones at the tumor margin. The model enables investigation of the invasive front and direct assessment of new drug candidates in human tissue - without the need for animal testing. The study of the Brain Tumor Translational Research Group has now been published in Nature Protocols. 

Highlights and Announcements

Get Involved in the TRA

As a member of the TRA, you can access funding opportunities, take part in events and build new networks. 

Become a member!

TRA members benefit from regular sponsorship offers and opportunities for networking beyond the boundaries of the specialist field. We look forward to meeting you!

Who are our members and what are their research topics?

Our members are professors and group leaders of the University of Bonn and cooperating Bonn institutions from medicine, life sciences, pharmacy, nutrition research, mathematics, computer science and other fields.

Meet our Researchers

Inter- and transdisciplinary research actively pursued at the University of Bonn and is promoted across faculty boundaries. The faces of TRA Life and Health are our Hertz Chair, our Argelander professors and the numerous committed scientists, such as the members of our steering committee.  

Contact

Avatar Brömer

Meike Brömer

TRA manager | Strategic Development and Quality Assurance Unit

Read more...

Transdisciplinary Research Areas

Spaces for innovation in research and teaching - these are the six transdisciplinary research areas at the University of Bonn. 

University of Excellence

Since summer 2019, we have been one of eleven German Universities of Excellence. Read more about our research profile and our future concept.

Research Funding

Research and Innovation Services at the University of Bonn will support you in all matters relating to your externally funded project.

Wird geladen